Method for preparing aliphatic isocyanate

US10654796B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10654796-B2
Application numberUS-201716469224-A
CountryUS
Kind codeB2
Filing dateDec 6, 2017
Priority dateDec 29, 2016
Publication dateMay 19, 2020
Grant dateMay 19, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a method capable of preparing high-purity aliphatic isocyanate, particularly, xylylene isocyanate in a high yield in a simple manner without an additional separate process, wherein when aliphatic isocyanate is prepared using phosgene, a side-reaction inhibitor capable of inhibiting side-reactions is introduced during phosgenation.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for preparing aliphatic isocyanate, comprising: reacting aliphatic amine or a salt thereof with phosgene in the presence of a compound of the following Chemical Formula 1: in Chemical Formula 1, R 1 to R 4 are each independently a C 1˜12 hydrocarbyl group, X is hydrogen, a hydroxyl group, or an acetamido group, and Y is an oxyl (O⋅) group or a C 1˜20 hydrocarbyloxy group. 2. The method of claim 1 , wherein R 1 to R 4 in Chemical Formula 1 are each independently a C 1˜4 alkyl group, X is hydrogen, a hydroxyl group, or an acetamido group, and Y is an oxyl group. 3. The method of claim 1 , wherein the compound of Chemical Formula 1 is selected from the group consisting of 2,2,6,6-tetramethylpiperidine 1-oxyl, 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl, and 4-acetamido-2,2,6,6-tetramethylpiperidine 1-oxyl. 4. The method of claim 1 , wherein the compound of Chemical Formula 1 is used in a molar ratio of 0.05 to 2 with respect to 100 moles of the aliphatic amine or the salt thereof. 5. The method of claim 1 , wherein the reacting with phosgene is performed in an organic solvent having a boiling point of 120° C. or higher. 6. The method of claim 1 , wherein the reacting with phosgene is performed in an organic solvent selected from the group consisting of an aromatic hydrocarbon-based organic solvent, an ester-based organic solvent, and a mixture thereof. 7. The method of claim 1 , comprising a first step of introducing the aliphatic amine or the salt thereof to a mixture which is prepared by dissolving the compound of Chemical Formula 1 and 50 wt % to 80 wt % of the total phosgene in an organic solvent at a temperature of −15° C. to −10° C.; and a second step of introducing and reacting the remainder of phosgene at 120° C. to 150° C. after completing the introduction of the aliphatic amine or the salt thereof. 8. The method of claim 7 , wherein the compound of Chemical Formula 1 is used in a molar ratio of 0.05 to 0.5 with respect to 100 moles of the aliphatic amine or the salt thereof. 9. The method of claim 1 , further comprising the step of preparing the salt of the aliphatic amine by reacting the aliphatic amine with hydrochloric acid or carbonic acid at a temperature of 30° C. or lower, before reacting with phosgene, wherein the reacting with phosgene is performed at 120° C. to 150° C. 10. The method of claim 9 , further comprising the step of preparing aliphatic amine-hydrochloride by reacting the aliphatic amine with hydrochloric acid in an organic solvent containing the compound of Chemical Formula 1 at a temperature of 30° C. or lower, before reacting with phosgene, wherein the compound of Chemical Formula 1 is used in a molar ratio of 0.15 to 0.8 with respect to 100 moles of the aliphatic amine or the salt thereof, and a concentration of the aliphatic amine in the organic solvent is 8 volume % to 10 volume %. 11. The method of claim 1 , wherein the aliphatic amine is xylylene diamine. 12. The method of claim 1 , wherein purity of the aliphatic isocyanate is 97% or more, and a content of monoisocyanate including ethylbenzyl isocyanate and chloromethylbenzyl isocyanate is 2.15% or less.

Assignees

Inventors

Classifications

  • Separation; Purification; Stabilisation; Use of additives · CPC title

  • C07C263/10Primary

    by reaction of amines with carbonyl halides, e.g. with phosgene · CPC title

  • having no double bonds between ring members or between ring members and non-ring members · CPC title

  • the carbon skeleton containing rings · CPC title

  • C07D211/94Primary

    Oxygen atom, e.g. piperidine N-oxide · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10654796B2 cover?
Provided is a method capable of preparing high-purity aliphatic isocyanate, particularly, xylylene isocyanate in a high yield in a simple manner without an additional separate process, wherein when aliphatic isocyanate is prepared using phosgene, a side-reaction inhibitor capable of inhibiting side-reactions is introduced during phosgenation.
Who is the assignee on this patent?
Hanwha Chemical Corp
What technology area does this patent fall under?
Primary CPC classification C07C263/10. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 19 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).